Mirae Asset Global Etfs Holdings Ltd. Compass Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 50,164 shares of CMPX stock, worth $178,583. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,164
Previous 61,040
17.82%
Holding current value
$178,583
Previous $115,000
13.04%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CMPX
# of Institutions
103Shares Held
101MCall Options Held
18.2KPut Options Held
2.51M-
Orbimed Advisors LLC San Diego, CA15.2MShares$54.2 Million1.41% of portfolio
-
Tang Capital Management LLC San Diego, CA13.5MShares$48 Million2.1% of portfolio
-
Blackstone Inc New York, NY10MShares$35.7 Million0.12% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.15MShares$25.5 Million0.64% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$23.5 Million0.0% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $361M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...